Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7266706rdf:typepubmed:Citationlld:pubmed
pubmed-article:7266706lifeskim:mentionsumls-concept:C0022658lld:lifeskim
pubmed-article:7266706lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:7266706lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:7266706lifeskim:mentionsumls-concept:C0033371lld:lifeskim
pubmed-article:7266706lifeskim:mentionsumls-concept:C0449438lld:lifeskim
pubmed-article:7266706lifeskim:mentionsumls-concept:C0205191lld:lifeskim
pubmed-article:7266706pubmed:issue2lld:pubmed
pubmed-article:7266706pubmed:dateCreated1981-10-14lld:pubmed
pubmed-article:7266706pubmed:abstractTextDecreased specific prolactin binding to kidney membrane preparations, and an upward trend in serum prolactin levels were observed concomitantly with the onset of chronic progressive nephropathy im male rats of the OFA Sandoz SPF strain. Females of the same strain developed a less severe form of the disease at a later age, but failed to show the changes in prolactin status seen in male rats. Nephropathy in both male and female animals was associated with morphological abnormalities of a predominantly tubular nature, but was not associated with development of renal failure as indicated by serum urea and creatinine levels. Possible mechanisms for the observed alterations in prolactin status are discussed.lld:pubmed
pubmed-article:7266706pubmed:languageenglld:pubmed
pubmed-article:7266706pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7266706pubmed:citationSubsetIMlld:pubmed
pubmed-article:7266706pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7266706pubmed:statusMEDLINElld:pubmed
pubmed-article:7266706pubmed:issn0028-2766lld:pubmed
pubmed-article:7266706pubmed:authorpubmed-author:RichardsonBBlld:pubmed
pubmed-article:7266706pubmed:authorpubmed-author:RatcliffeJ...lld:pubmed
pubmed-article:7266706pubmed:authorpubmed-author:CowdenE AEAlld:pubmed
pubmed-article:7266706pubmed:authorpubmed-author:KennedyA CAClld:pubmed
pubmed-article:7266706pubmed:authorpubmed-author:DobbieJ WJWlld:pubmed
pubmed-article:7266706pubmed:authorpubmed-author:MountjoyKKlld:pubmed
pubmed-article:7266706pubmed:issnTypePrintlld:pubmed
pubmed-article:7266706pubmed:volume27lld:pubmed
pubmed-article:7266706pubmed:ownerNLMlld:pubmed
pubmed-article:7266706pubmed:authorsCompleteYlld:pubmed
pubmed-article:7266706pubmed:pagination84-8lld:pubmed
pubmed-article:7266706pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7266706pubmed:meshHeadingpubmed-meshheading:7266706-...lld:pubmed
pubmed-article:7266706pubmed:meshHeadingpubmed-meshheading:7266706-...lld:pubmed
pubmed-article:7266706pubmed:meshHeadingpubmed-meshheading:7266706-...lld:pubmed
pubmed-article:7266706pubmed:meshHeadingpubmed-meshheading:7266706-...lld:pubmed
pubmed-article:7266706pubmed:meshHeadingpubmed-meshheading:7266706-...lld:pubmed
pubmed-article:7266706pubmed:meshHeadingpubmed-meshheading:7266706-...lld:pubmed
pubmed-article:7266706pubmed:meshHeadingpubmed-meshheading:7266706-...lld:pubmed
pubmed-article:7266706pubmed:meshHeadingpubmed-meshheading:7266706-...lld:pubmed
pubmed-article:7266706pubmed:meshHeadingpubmed-meshheading:7266706-...lld:pubmed
pubmed-article:7266706pubmed:meshHeadingpubmed-meshheading:7266706-...lld:pubmed
pubmed-article:7266706pubmed:year1981lld:pubmed
pubmed-article:7266706pubmed:articleTitleProlactin status in chronic nephropathy in the rat.lld:pubmed
pubmed-article:7266706pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7266706pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed